German chemical distributor Brenntag is aiming for an initial public offering in the first half of 2010, most likely before the Easter holidays in early April, two people familiar with the matter told Reuters. Brenntag had no immediate comment.
Brenntag, bought by private equity group BC Partners for more than €3 billion in 2006, had sales of €7.4 billion in 2008 and has about 11,000 employees in more than 64 countries.
Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.
The versatile material polymethyl methacrylate (PMMA) is particularly impressive due to its durability and outstanding recyclability.
GenSight Biologics recently announced the successful transfer of the upstream phase of the manufacturing process for LUMEVOQ, the Company’s gene therapy candidate product to CDMO Catalent.
